ClinicalTrials.gg
RecruitingNCT06888713Updated Oct 22, 2026

Telemonitoring of Activities of Daily Living in Home Care Services of Older Adults With Cognitive Deficits

An interventional study of Telemonitoring of ADL in Dementia, sponsored by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal. Recruiting at 3 sites in Canada. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Apr 2025; still recruiting 1 year 7 months later.
Updated Oct 22, 2026Now RecruitingFirst site in Canada+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Non-randomized
Ages
65 Years and older
Sex
All
01

Study summary

In Canada, it is estimated that two million people are users of publicly funded home care services, with more than half of them being 65 years and older. Although home care services are considered a priority by Canadian provinces, in Québec alone, more than 46 000 people were waiting for those services in 2022. The provision of home care services is hampered by limited funding and growing demand from among an aging population, among other factors. These challenges have led to urgent calls to better support home care in Canada to ensure optimal use of scarce human and financial resources. One of the key strategies to achieve optimal use of resources may be remote monitoring of activities of daily living (ADLs), a type of telehealth. ADL telemonitoring can remotely recognize ADLs such as preparing meals and moving around the home. Past studies have shown that ADL telemonitoring can help in better understanding older adults' home care needs, thereby allowing for more personalized ADL interventions. Previous projects have also allowed for the developement of NEARS-SAPA, a telemonitoring system for ADLs. In these past projects, it was identified how NEARS-SAPA was used by home care services and its ease of use was tested in real environments. In the present project, the benefits of ADL telemonitoring will be tested and its technological capabilities expanded, hence preparing the system for the next big step, i.e. large-scale adoption by home care services. Ultimately, ADL telemonitoring may help the healthcare system determine which service is more appropriate for which person and at what time, thereby optimizing interventions and resource management.

02

Conditions studied

  • Dementia

Browse trials for

Keywords

  • Telemonitoring of ADL
  • Homecare services
  • IA
03

In context

Dementia

2,372 studies on the registry are indexed under Dementia; 574 are open to participants now.

This study's planned enrollment of 200 is above the median of 90 across 1,758 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal is the lead sponsor of 18 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

1) be an older adult (> 65 years old), 2) have cognitive deficits as reported in the medical record, 3) live alone, at home, 4) be a care recipient of home care services, 5) speak French or English

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Telemonitoring of ADL group

    Will receive the technology in their home to document if it influenced the homecare services plan.

    Other: Telemonitoring of ADL

  • No intervention
    No telemonitoring of ADL

    Another group will be followed in therms of homecare services received, but without the technology. The control group will be gathered based on archives data only.

Interventions

  • OtherTelemonitoring of ADL

    Telemonitoring of ADL is based on smart environments sensors (non wearables) and gathers information about activity of daily living routines for a better understanding of homecare services needed.

06

What researchers measure

Primary outcomes

  1. Number of homecare services received to support activities of daily living (ADL)

    Number of homecares ADL services received as identified in clinical databases.

    Time frame: From enrollment until around 12 months of following.

  2. Nature of homecare services received to support activities of daily living (ADL).

    The category of services received related to ADL as indicated in clinical databases.

    Time frame: From enrollement until around 12 months of following.

07

Study locations

3 of 3 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Not yet recruiting→Recruiting
changed Oct 22, 2026
Sites
3 sites added — first site in Canada
Show 3 added (3 Canada)
  • CIUSSS Centre-sud-de-l'île-de-Montréal · Montreal, Canada
  • CIUSSS de l'Est-de-l'île-de-Montréal · Montreal, Canada
  • CIUSSS Saguenay-Lac-St-Jean · Montreal, Canada
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Not yet recruiting→Recruiting
    3 sites added — first site in Canada
    Show 3 added (3 Canada)
    • CIUSSS Centre-sud-de-l'île-de-Montréal · Montreal, Canada
    • CIUSSS de l'Est-de-l'île-de-Montréal · Montreal, Canada
    • CIUSSS Saguenay-Lac-St-Jean · Montreal, Canada
    + 6 other changes: index terms, identifiers, verification date, date precision, oversight details and criteria formatting

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06888713
Lead sponsor
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal
Responsible party
Nathalie Bier (Full professor, Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal) — Principal investigator
First posted
Mar 21, 2025
Start date
Apr 1, 2025
Primary completion
Apr 1, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Oct 22, 2026

Study contacts

Maxime Lussier, Ph.D.
Contact
maxime.lussier.ccsmtl@ssss.gouv.qc.ca
514-340-3540
Nathalie Bier, Ph.D.
principal investigator · CRIUGM, Université de Montréal
Charles Gouin-Vallerand, Ph.D.
principal investigator · Université de Sherbrooke
Kevin Bouchard, Ph.D.
principal investigator · Université du Québec à Chicoutimi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion